This article highlights groundbreaking research on tuberculosis (TB) treatment, revealing why a key TB drug remains effective against resistant strains. Rutgers Health researchers uncover the molecular mechanisms that enable this drug to combat TB bacteria, potentially inspiring improved treatments and drug development strategies...
Favorite
General Public
Government Agencies
Health Educators/Communicators
Health Professionals
Physicians
Policy Makers
2025
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually...
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2023
This program manual provides information on the NYC Department of Health’s policies, protocols, and recommendations for the prevention, treatment, and control of TB.
Favorite
Nurses
Physicians
2022
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually...
Favorite
Policy Makers
International Agencies
Managers and Supervisors
2022
Today, TB Alliance held a virtual meeting of its Stakeholders Association and other tuberculosis (TB) and global health stakeholders around the world to highlight the recent rapid communication issued by the World Health Organization (WHO) Global Tuberculosis Programme regarding updated guidelines for treating drug-resistant tuberculosis (DR-TB) and their potential impact on DR-TB therapy...
Favorite
2022
This guide provides clinicians with an overview of drug-resistant tuberculosis. The guide includes tools that can be used by providers who participate in the management of patients with drug-resistant TB.
Favorite
Civil Surgeons
Nurses
Physicians
2022
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually...
Favorite
International Agencies
Policy Makers
2020
The infographic provides information on the importance of CDC's Molecular Detection of Drug Resistance (MDDR) service, how drug resistance develops, and how CDC assists TB programs. The infographic also includes a case study.
Favorite
General Public
Lab Personnel
2020
This guide details 2020 updates to the WHO guidelines about the global standard of care for drug-resistant TB. The guide also includes messaging and strategies that can be used to advocate for WHO-recommended regimens.
Favorite
International Agencies
Policy Makers
2020
This one-page flow diagram for clinicians and health-care providers lists remarks and side effects of second-line drugs used to treat MDR-TB. It provides information on the measured MIC, serum levels, and dosing of each drug.
Favorite
Nurses
Physicians
2020
This resource presents a method of assessing and updating laboratory procedures to assist in detecting TB early by reducing lab turnaround time for reporting positive smear, culture, identification, and susceptibility results.
Favorite
Lab Personnel
2019
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2019
Popularly known as “The Orange Guide”, the 7th edition this guide provides practical guidance to health workers on the front line of TB control. The guide has been updated with new information on the management of persons with TB infection, bacteriological diagnosis of tuberculosis, treatment of drug-resistant TB, and more.
Favorite
International Agencies
Managers and Supervisors
2019
This document informs national TB programs and stakeholders about the key implications for the treatment of drug-resistant tuberculosis. This resource is available before the release of the updated guidelines in order for planning at the country level. The guidelines are expected to be released in 2020...
Favorite
Physicians
International Agencies
2019
Laboratory services, such as sputum specimen diagnosis, are vital to effective TB control. This resource may be used by laboratories to develop institutional policies that support proper collection and submission of sputum specimens for TB testing.
Favorite
Lab Personnel
2018
